Indication
Tear film insufficiency
Tear film insufficiency refers to an ocular surface disorder characterized by a quantitative deficiency or qualitative instability in the precorneal tear film, encompassing conditions such as aqueous-deficient dry eye disease and evaporative dry eye states. Read more about Tear film insufficiency
8 drugs 8 manufacturers
Drugs that treat it
Common Tear film insufficiency therapies.
XIIDRA (lifitegrast)
XIIDRA (lifitegrast)
XIIDRA (lifitegrast)
TYRVAYA (varenicline tartrate)
VEVYE (cyclosporine)
XIIDRA (lifitegrast)
TYRVAYA (varenicline tartrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonTear film insufficiency refers to an ocular surface disorder characterized by a quantitative deficiency or qualitative instability in the precorneal tear film, encompassing conditions such as aqueous-deficient dry eye disease and evaporative dry eye states.
It affects the ocular system, particularly the cornea and conjunctiva, frequently occurring in older adults, contact lens wearers, and individuals with autoimmune diseases or meibomian gland dysfunction.
Pathophysiologically, lacrimal gland hyposecretion, lipid layer abnormalities, or altered mucin production lead to tear hyperosmolarity, rapid tear film breakup, and ocular surface inflammation.
Patients typically present with ocular discomfort, foreign body sensation, burning, hyperemia, and transient or fluctuating visual disturbances.
- nih.gov
Tear film insufficiency refers to an ocular surface disorder characterized by a quantitative deficiency or qualitative instability in the precorneal tear film, encompassing conditions such as aqueous-deficient dry eye disease and evaporative dry eye states Pathophysiologically, lacrimal gland hyposecretion, lipid layer abnormalities, or altered mucin production lead to tear hyperosmolarity, rapid tear film breakup, and ocular surface inflammation
- nih.gov
Tear film insufficiency refers to an ocular surface disorder characterized by a quantitative deficiency or qualitative instability in the precorneal tear film, encompassing conditions such as aqueous-deficient dry eye disease and evaporative dry eye states It affects the ocular system, particularly the cornea and conjunctiva, frequently occurring in older adults, contact lens wearers, and individuals with autoimmune diseases or meibomian gland dysfunction Pathophysiologically, lacrimal gland hyp...
- nih.gov
It affects the ocular system, particularly the cornea and conjunctiva, frequently occurring in older adults, contact lens wearers, and individuals with autoimmune diseases or meibomian gland dysfunction
- aao.org
It affects the ocular system, particularly the cornea and conjunctiva, frequently occurring in older adults, contact lens wearers, and individuals with autoimmune diseases or meibomian gland dysfunction
- nih.gov
Patients typically present with ocular discomfort, foreign body sensation, burning, hyperemia, and transient or fluctuating visual disturbances
- aao.org
Patients typically present with ocular discomfort, foreign body sensation, burning, hyperemia, and transient or fluctuating visual disturbances
Personalize your experience
Follow Tear film insufficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.